Citizen Portal
Sign In

Get Full Government Meeting Transcripts, Videos, & Alerts Forever!

Sen. introduces bill to ban prior authorization for HIV antivirals in state plans; one-person testimony recounts medication access disruption

Senate Health and Long Term Care Committee · January 22, 2026
AI-Generated Content: All content on this page was generated by AI to highlight key points from the meeting. For complete details and context, we recommend watching the full video. so we can fix them.

Summary

SB 6183 would require health carriers, including public-employee plans, to cover all FDA-approved HIV antiviral drugs without prior authorization, step therapy or other utilization-management protocols beginning Jan. 1, 2027. The prime sponsor said Medicaid results were promising; a person living with HIV testified that insurance changes once made their viral load detectable by blocking access to medication.

Senator (identified in the transcript as the prime sponsor) presented Senate Bill 6183 to the Senate Health and Long Term Care Committee on Jan. 22, proposing that health carriers, including plans offered to public employees, provide coverage for all FDA-approved HIV antiviral drugs without prior authorization, step therapy or other utilization-management protocols beginning Jan. 1, 2027.

Greg Attenasio, committee staff, briefed members on the bill and noted the Food and Drug Administration’s approval…

Already have an account? Log in

Subscribe to keep reading

Unlock the rest of this article — and every article on Citizen Portal.

  • Unlimited articles
  • AI-powered breakdowns of topics, speakers, decisions, and budgets
  • Instant alerts when your location has a new meeting
  • Follow topics and more locations
  • 1,000 AI Insights / month, plus AI Chat
30-day money-back on paid plans